Published in J Cell Biol on May 01, 1986
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg (1987) 1.49
Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J Cell Biol (1992) 1.06
Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. Am J Pathol (1989) 1.05
Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol (1990) 1.02
Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol (1990) 1.01
Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth. J Cell Biol (1990) 1.00
Interaction of heparin with synthetic antithrombin III peptide analogues. Biochem J (1994) 0.96
Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture. J Cell Biol (1989) 0.94
Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am J Pathol (1991) 0.93
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial. Cancer Chemother Pharmacol (2007) 0.87
Protamine and protamine-insulins exacerbate the vascular response to injury. J Clin Invest (1993) 0.86
The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype. Biomaterials (2009) 0.85
Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. Mol Cell Biol (1991) 0.84
Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle. Br J Pharmacol (2005) 0.84
Effect of heparin on pulmonary fibroblasts and vascular cells. Thorax (1992) 0.83
Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem Cell Biol (2003) 0.81
Evaluation of a novel thermosensitive heparin-poloxamer hydrogel for improving vascular anastomosis quality and safety in a rabbit model. PLoS One (2013) 0.80
Cell surface heparan sulfate proteoglycan and chondroitin sulfate proteoglycan of arterial smooth muscle cells. Am J Pathol (1992) 0.77
Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes. Thrombosis (2011) 0.77
Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cells. J Exp Med (1987) 0.76
Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound. Exp Clin Cardiol (2002) 0.75
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol (1981) 3.41
Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (1977) 3.25
Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res (1980) 2.40
Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res (1980) 2.00
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem (1982) 1.99
Plasma heparin: a unique, practical, submicrogram-sensitive assay. J Lab Clin Med (1973) 1.91
Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun (1983) 1.62
Multiple functional domains of the heparin molecule. Proc Natl Acad Sci U S A (1981) 1.45
Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. J Cell Physiol (1984) 1.29
Secondary femoropopliteal reconstruction. Ann Surg (1981) 1.29
Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest (1981) 1.23
Myosin in cultured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression. J Cell Biol (1984) 1.10
Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238). Thromb Res (1978) 1.03
Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin. Thromb Res (1982) 0.87
Inhibition of purified plasma kallikrein by antithrombin III and heparin. Thromb Res (1975) 0.84
The inhibition of human plasma kallikrein by antithrombin III. Thromb Res (1975) 0.84
Synthetic heparin fragments: new and efficient tools for the study of heparin and its interactions. Nouv Rev Fr Hematol (1984) 0.83
The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem (1966) 46.81
The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol (1967) 11.45
Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J Cell Biol (1967) 11.07
Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol (1967) 9.74
Freeze-etching nomenclature. Science (1975) 7.41
Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01
Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol (1968) 4.22
Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers. J Exp Med (1966) 4.09
Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol (1974) 3.77
Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol (1967) 3.53
Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol (1981) 3.41
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A (1977) 3.31
Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol (1975) 3.24
Contraction of isolated brush borders from the intestinal epithelium. J Cell Biol (1976) 3.22
Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J Biol Chem (1980) 3.20
Degranulation of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 3.17
The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A (1997) 3.09
Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest (1975) 2.88
A comparative evaluation of the distribution of concanavalin A-binding sites on the surfaces of normal, virally-transformed, and protease-treated fibroblasts. Proc Natl Acad Sci U S A (1973) 2.88
Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci U S A (1976) 2.82
An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65
Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med (1970) 2.61
Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell Immunol (1976) 2.61
Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties. J Exp Med (1972) 2.49
Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res (1980) 2.40
Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest (1980) 2.32
Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature (1999) 2.27
The concept of lipid domains in membranes. J Cell Biol (1982) 2.26
Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem (1992) 2.24
Evidence for a blood-thymus barrier using electron-opaque tracers. J Exp Med (1972) 2.18
The distributions of some granule-associated enzymes in guinea-pig polymorphonuclear leucocytes. Biochem J (1970) 2.16
The adhesive interaction between polymorphonuclear leukocytes and endothelial cells in vitro. Cell (1978) 2.13
An ultrastructural staining method for enhancing the size and electron opacity of ferritin in thin sections. J Histochem Cytochem (1972) 2.12
Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med (1973) 2.08
Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci U S A (1984) 2.06
A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry (1978) 2.05
Degradation of abnormal proteins in Escherichia coli. Formation of protein inclusions in cells exposed to amino acid analogs. J Biol Chem (1975) 2.03
An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int (1975) 2.01
Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res (1980) 2.00
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem (1982) 1.99
The ultrastructural basis of alveolar-capillary membrane permeability to peroxidase used as a tracer. J Cell Biol (1968) 1.99
Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. J Cell Sci (1980) 1.90
Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry (1985) 1.89
Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells. J Clin Invest (1976) 1.89
Redistribution and fate of Ig complexes on surface of B lymphocytes: functional implications and mechanisms. Transplant Rev (1973) 1.88
Distribution of endogenous albumin in the rat glomerulus: role of hemodynamic factors in glomerular barrier function. Kidney Int (1976) 1.88
The structure of the zonula occludens. A single fibril model based on freeze-fracture. J Cell Biol (1974) 1.87
Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int (1978) 1.83
Factors affecting the redistribution of surface-bound concanavalin A on human polymorphonuclear leukocytes. J Cell Biol (1974) 1.78
Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers. Nature (1974) 1.75
Autophagic vacuoles in experimental atrophy. Exp Mol Pathol (1971) 1.75
Endocytosis by lymphocytes of complexes of anti-Ig with membrane-bound Ig. J Immunol (1972) 1.73
An ultrastructural study of glomerular permeability using catalase and peroxidase as tracer proteins. J Exp Med (1970) 1.70
Vascular leakage induced by horseradish peroxidase in the rat. Proc Soc Exp Biol Med (1967) 1.67
Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci (1988) 1.66
Exogenous cytochrome c as an ultrastructural tracer. J Histochem Cytochem (1969) 1.65
Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun (1983) 1.62
Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci U S A (1993) 1.61
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun (1976) 1.60
Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci U S A (1982) 1.58
Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin. J Biol Chem (1984) 1.57
Glomerular cells in culture. Kidney Int (1983) 1.57
A general method for permeabilizing monolayer and suspension cultured animal cells. Exp Cell Res (1979) 1.56
Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest (1992) 1.55
Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Carbohydr Res (1990) 1.53
Mapping and migration of lymphocyte surface macromolecules. Fed Proc (1973) 1.51
Ligand-induced movement of lymphocyte surface macromolecules. IV. Stimulation of cell motility by anti-Ig and lack of relationship to capping. J Exp Med (1974) 1.51
Evaluation of the polyene antibiotic filipin as a cytochemical probe for membrane cholesterol. J Histochem Cytochem (1980) 1.51
Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J Cell Physiol (1985) 1.50
Brownian motion: a theoretical explanation for the movement of vesicles across the endothelium. Nature (1966) 1.48
Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier. Proc Natl Acad Sci U S A (1979) 1.48
The structural basis of glomerular filtration. Adv Nephrol Necker Hosp (1972) 1.44
Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem (1992) 1.42
Ligand-induced movement of lymphocyte membrane macromolecules. V. Capping, cell movement, and microtubular function in normal and lectin-treated lymphocytes. J Exp Med (1974) 1.41
Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes. Lab Invest (1972) 1.41
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem J (1981) 1.39
Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int (1988) 1.39
Surface localization of 5'-nucleotidase on the mouse lymphocyte. J Histochem Cytochem (1977) 1.38
Cryoprotectant-induced redistribution of intramembranous particles in mouse lymphocytes. J Cell Biol (1974) 1.38
Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci U S A (1982) 1.37
Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci U S A (1993) 1.36
Model for capping derived from inhibition of surface receptor capping by free fatty acids. Proc Natl Acad Sci U S A (1980) 1.36
Improved methods for culturing rat glomerular cells. Kidney Int (1984) 1.36
An ultrastructural study of glomerular permeability in aminonucleoside nephrosis using catalase as a tracer protein. J Exp Med (1970) 1.35
Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol (1985) 1.35
Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci U S A (1980) 1.34
Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J Biol Chem (1998) 1.34